Shroom Scan #117: Psilocybin remission reaches 53%, suicidal thoughts ease, and hidden compounds in shiitake stems

Hi Shroomers. Good morning, and sorry for the delay! I usually schedule this at 4:00 a.m. local time, and mistakenly set it for the afternoon. So here I am in your inbox a bit late.

The most useful mushroom research right now is moving in two directions: what helps people feel better faster, and what helps us stop wasting what already works.

This week, psilocybin keeps showing up in places where the need is urgent: depression that doesn’t respond to standard medication, chronic suicidal thoughts, eating disorder recovery, and social anxiety treatment models.

On the functional side, the story is less mystical and more practical. Shiitake stems may be more valuable than we thought, root fungi can help crops use fertilizer more efficiently, and better beta-glucan testing could make mushroom supplement labels a lot less confusing. In other words: the future of mushrooms is not just new discoveries. It’s better use, better testing, and better proof.

Don't toss stems 🔪 Shiitake (Lentinula edodes) stems yielded three natural compounds that reduced the activity of blood sugar and blood pressure enzymes by more than 60% at 1 mg/mL. The compounds showed no significant toxicity in intestinal cells, highlighting unexpected value in a mushroom part often treated as waste. Scientists are increasingly finding that stems contain concentrated bioactive compounds, not just the caps.

Hidden drug factory 🧪 Daedaleopsis confragosa, a wood-growing bracket mushroom, contained steroidal compounds that blocked Src, a key protein involved in breast cancer growth and survival. Multiple compounds slowed cancer-cell activity in laboratory experiments, adding to the growing list of medically interesting molecules discovered in fungi. Even obscure mushrooms are proving to be rich sources of compounds with pharmaceutical potential.

Dinner plate upgrade 🍽️ Lion's mane (Hericium erinaceus) combines a crab-like texture, savory umami flavor, fiber, protein, and naturally occurring compounds such as erinacines, hericenones, and ergothioneine. Few mushrooms bridge the gap between gourmet ingredient and functional wellness staple as completely as lion's mane.

Beyond antidepressants 💡 For people whose depression persists after multiple medications, newer treatments are delivering results on dramatically shorter timelines. Esketamine can begin working within hours, while a single 25 mg psilocybin session reduced depression scores by twice as much as a control dose in a 233-person trial and produced meaningful improvement in 37% of participants. Researchers are increasingly focusing on treatments that trigger lasting brain changes rather than requiring daily symptom management.

Rebuilding body trust 💛 Across eight studies, people using psychedelic treatments for eating disorders described becoming less critical of their bodies and more aware of hunger, emotions, and self-care. Many reported fewer obsessive thoughts around food, greater emotional resilience, and a stronger sense of identity beyond the disorder. Recovery was often described as reconnecting with themselves rather than simply changing eating habits.

One dose impact 💧 Adults with major depression experienced symptom improvements within 48 hours after a single 25 mg psilocybin session, with benefits lasting beyond 100 days on self-reported measures. More than half of participants (52.9%) reached remission by 6 weeks versus just 5.9% in the placebo group, highlighting one of the fastest antidepressant responses seen in psychiatric research.

Hope after years 🌅 Twenty adults with chronic suicidal thoughts and at least two prior antidepressant treatment failures received a single 25 mg psilocybin session, with suicidal-thinking scores dropping by nearly 14 points after 3 weeks. Improvements appeared within 1 week, remained significant through 12 weeks, and 70% of participants reported minimal or no suicidal thoughts by the end of follow-up. No serious adverse events were reported.

Practice social confidence 🎭 Researchers are pairing virtual reality therapy with low-dose psilocybin to help people practice stressful social situations such as interviews and group interactions in a controlled setting. The trial will test 3 mg doses taken every third day in 32 adults with social anxiety disorder, looking for improvements beyond therapy alone. If successful, it could open the door to new ways of treating one of the world's most common anxiety conditions.

Hidden mushroom diversity 🌎 Scientists confirmed lion's mane (Hericium erinaceus) growing in multiple regions of Mexico, adding only the second formally documented record of the species in the country. Four strains displayed different growth speeds and colony structures depending on the nutrients available, showing that not all lion's mane mushrooms behave the same way. These local varieties could help improve cultivation and expand access to regionally adapted genetics.

Fungi feed crops 🌾 Root-dwelling fungi help plants pull phosphorus from soil, a nutrient crops need for strong growth but often cannot access on their own. In groundnut, wheat, soybean, and maize, these fungi raised yields by 10–35% and improved phosphorus uptake by up to 45%. Better fungal partnerships could mean healthier soil, less fertilizer waste, and more resilient food production.

What's really inside 🔍 Mushroom supplements often advertise beta-glucans, but fillers, starches, and sweeteners can make testing less accurate. A refined lab method improved beta-glucan measurement across mushrooms, yeast, algae, gummies, tinctures, and capsules while reducing testing time from 7 hours to 4 hours and 25 minutes. More accurate testing helps separate well-made mushroom products from confusing labels.

Pressure support 📏 Wine cap mushroom (Stropharia rugosoannulata) is rich in protein and peptides, with dried mushrooms containing up to 50% protein and 15% free peptides. Using four ultrasound frequencies helped extract more of these compounds, reaching 60% protein and 34% peptides, and the resulting mixture showed blood-pressure-related activity comparable to captopril in testing. Better extraction could turn edible mushrooms into more potent heart-health ingredients.